Skip to main content
SpringerLink
Log in

Chemotherapy of lepromatous leprosy: Recent developments and prospects for the future

  • Current Topic: Review
  • Published:
European Journal of Clinical Microbiology and Infectious Diseases Aims and scope Submit manuscript

Abstract

Leprosy is a major debilitating infectious disease, primarily of the developing world. In this paper the current status and future prospects of antimicrobial therapy of the severe anergic lepromatous form of the disease are reviewed. Until the last few years only dapsone, rifampicin, clofazimine and ethionamide have had practical application in its therapy, and only rifampicin was bactericidal. Recently, antibiotics from three different classes have been found to be bactericidal in lepromatous patients: a tetracycline (minocycline), a macrolide (clarithromycin), and several fluoroquinolones (including pefloxacin, ofloxacin and sparfloxacin). Against a background of drug resistance and bacterial persistence, recommendations for multidrug therapy and the means to devise rationally based therapy for the future are discussed.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Franzblau SG Drug susceptibility testing ofMycobacterium leprae in the BACTEC 460 system. Antimicrobial Agents and Chemotherapy 1989, 33: 2115–2117.

    PubMed  Google Scholar 

  2. Ramasesh N, Krahenbuhl JL, Hastings RC In vitro effects of antimicrobial agents onMycobacterium leprae in mouse peritoneal macrophages. Antimicrobial Agents and Chemotherapy 33, 1989: 657–662.

    PubMed  Google Scholar 

  3. Shepard CC The experimental disease that follows the injection of human leprosy bacilli into foot-pads of mice. Journal of Experimental Medicine 1960, 112: 445–454.

    Article  Google Scholar 

  4. Shepard CC, Walker LL, Van Landingham RM, Redus MA Kinetic testing of drugs againstMycobacterium leprae in mice. Activity of cephaloridine, rifampin, streptovaricin, vadrine, and viomycin. American Journal of Tropical Medicine and Hygiene 1971, 20: 616–620.

    PubMed  Google Scholar 

  5. Colston MJ, Hilson GR, Banerjee DK The “proportional bactericidal test”: a method for assessing bactericidal activity in drugs againstMycobacterium leprae in mice. Leprosy Review 1978, 49: 7–15.

    PubMed  Google Scholar 

  6. Shepard CC Statistical analysis of results obtained by two methods for testing drug activity againstMycobacterium leprae. International Journal of Leprosy 1982, 50: 96–101.

    Google Scholar 

  7. Colston MJ, Ellard GA, Gammon PT Drugs for combine therapy: experimental studies on the antileprosy activity of ethionamide and prothionamide, and a general review. Leprosy Review 1978, 49: 115–126.

    PubMed  Google Scholar 

  8. Shepard CC A brief review of experiences with short-term clinical trials monitored by mouse-footpad inoculation. Leprosy Review 1981, 52: 299–308.

    Google Scholar 

  9. Erickson PT Relapse following apparent arrest of leprosy by sulfone therapy. Public Health Reports 1950, 65: 1147–1157. Reprinted in International Journal of Leprosy 1951, 19: 63–74.

    PubMed  Google Scholar 

  10. Price RB Relapse of leprosy in American Samoa. American Journal of Tropical Medicine and Hygiene 1959, 8: 358–363.

    PubMed  Google Scholar 

  11. Waters MFR, Rees RJW, Laing ABG, Fah KK, Meade TW, Parikshak N, North WRS The rate of relapse in lepromatous leprosy following completion of twenty years of supervised sulphone therapy. Leprosy Review 1986, 57: 101–109.

    Google Scholar 

  12. Ji BH Drug resistance in leprosy: a review. Leprosy Review 1985, 56: 265–278.

    PubMed  Google Scholar 

  13. Gelber RH, Rea TH, Murray LP, Siu P, Tsang M, Byrd S Primary dapsone-resistant Hansen's disease in California: experience with over 100Mycobacterium leprae isolates. Archives of Dermatology 1990, 126: 1584–1586.

    Article  PubMed  Google Scholar 

  14. Gelber RH The killing ofMycobacterium leprae in mice by various dietary concentrations of clofazimine and ethionamide. Leprosy Review 1987, 58: 407–411.

    PubMed  Google Scholar 

  15. Rees RJW, Pearson JMH, Waters MFR Experimental and clinical studies on rifampicin in treatment of leprosy. British Medical Journal 1970, 1: 89–92.

    PubMed  Google Scholar 

  16. Gelber RH The killing ofMycobacterium leprae in mice by various dietary concentrations of dapsone and rifampicin. Leprosy Review 1986, 57: 347–353.

    PubMed  Google Scholar 

  17. Shepard CC, Levy L, Fasal P Rapid bactericidal effect of rifampicin onM. leprae. American Journal of Tropical Medicine and Hygiene 1972, 21: 446–449.

    PubMed  Google Scholar 

  18. World Health Organization Study Group Chemotherapy of leprosy for control programmes. Technical Report Series No. 675. World Health Organization, Geneva, 1982.

    Google Scholar 

  19. World Health Organization Expert Committee on Leprosy: Sixth Report. Technical Report Series 768. World Health Organization, Geneva, 1988.

  20. Cartel JL, Naudillon Y, Artus JC, Grosset JH Hepatotoxicity of the daily combination of 5 mg/kg protionamide + 10 mg/kg rifampin. International Journal of Leprosy 1985, 53: 15–18.

    Google Scholar 

  21. Gelber RH Activity of minocycline inMycobacterium leprae-infected mice. Journal of Infectious Diseases 1987, 156: 236–239.

    PubMed  Google Scholar 

  22. Ji B, Perani EG, Grosset JH Effectiveness of clarithromycin and minocycline alone or in combination against experimentalMycobacterium leprae infection in mice. Antimicrobial Agents and Chemotherapy 1991, 35: 579–581.

    PubMed  Google Scholar 

  23. Gelber RH, Siu P, Tsang M, Alley P, Murray L Effect of low-level and intermittent minocycline therapy on the growth ofMycobacterium leprae in mice. Antimicrobial Agents and Chemotherapy 1991, 35: 992–994.

    PubMed  Google Scholar 

  24. Gelber RH, Fukuda K, Byrd S, Murray LP, Siu P, Tsang M, Rea TH A clinical trial of minocycline in lepromatous leprosy. British Medical Journal 1992, 304: 91–92.

    PubMed  Google Scholar 

  25. Ji B, Jamet P, Perani EG, Bobin P, Grosset JH Powerful bactericidal activities of clarithromycin and minocycline againstMycobacterium leprae in lepromatous leprosy. Journal of Infectious Diseases 1993, 168: 188–190.

    PubMed  Google Scholar 

  26. Suomalainen K, Sorsa T, Golub LM, Ramamurthy N, Lee H-M, Uitto V-J, Saari H, Konttinen YT Specificity of the anticollaginase action of tetracyclines; relevance to their anti-inflammatory potential. Antimicrobial Agents and Chemotherapy 1992, 36: 227–229.

    PubMed  Google Scholar 

  27. Franzblau SG, Hastings RC In vitro and in vivo activities of macrolides againstMycobacterium leprae. Antimicrobial Agents and Chemotherapy 1988, 32: 1758–1762.

    PubMed  Google Scholar 

  28. Gelber RH, Siu P, Tsang M, Murray LP Activities of various macrolide antibiotics againstMycobacterium leprae infection in mice. Antimicrobial Agents and Chemotherapy 1991, 35: 760–763.

    PubMed  Google Scholar 

  29. Gelber RH, Murray LP, Siu P, Tsang M Clarithromycin at very low levels and on intermittent administration inhibits the growth ofM. leprae in mice. International Journal of Leprosy 1992, 60: 485–487.

    Google Scholar 

  30. Ji B, Perani EG, Petinon C, Grosset JH Bactericidal activities of single or multiple doses of various combinations of new antileprosy drugs and/or rifampin againstM. leprae in mice. International Journal of Leprosy 1992, 60: 556–561.

    Google Scholar 

  31. Chan GP, Garcia-Ignacio BY, Chavez VE, Livelo JB, Jimenez CL, Parilla MLR, Franzblau SG Clinical trial of clarithromycin for lepromatous leprosy. Antimicrobial Agents and Chemotherapy 1994, 38: 515–517.

    PubMed  Google Scholar 

  32. Saito H, Tomioka H, Nagashima K In vitro an in vivo activity of ofloxacin againstMycobacterium leprae infection induced in mice. International Journal of Leprosy 1986, 54: 560–562.

    Google Scholar 

  33. Guelpa-Lauras CC, Perani EG, Giroir AM, Grosset TH Activity of pefloxacin and ciprofloxacin againstMycobacterium leprae in the mouse. International Journal of Leprosy 1987, 55: 70–77.

    Google Scholar 

  34. Grosset JH, Guelpa-Lauras CC, Perani EG, Beoletto C Activity of ofloxacin againstMycobacterium leprae in the mouse. International Journal of Leprosy 1988, 56: 259–264.

    Google Scholar 

  35. Tsutsumi S, Gidoh M Studies on the development of novel antileprous chemotherapeutics using nude mice with special reference to a new quinolone carboxylic acid, AT-4140. Japanese Journal of Leprosy 1989, 58: 250–258.

    PubMed  Google Scholar 

  36. Franzblau SG, White KE Comparative in vitro activities of 20 fluoroquinolones againstMycobacterium leprae. Antimicrobial Agents and Chemotherapy 1990, 34: 229–231.

    PubMed  Google Scholar 

  37. Gelber RH, Siu P, Tsang M, Murray LP Activities of various macrolide antibiotics againstMycobacterium leprae infection in mice. Antimicrobial Agents and Chemotherapy 1991, 35: 760–763.

    PubMed  Google Scholar 

  38. Franzblau SG, Parrilla MLR, Chan GP Sparfloxacin is more bactericidal than ofloxacin againstMycobacterium leprae in mice. International Journal of Leprosy 1993, 61: 66–69.

    Google Scholar 

  39. Pattyn SR Activity of ofloxacin and pefloxacin againstMycobacterium leprae in mice. Antimicrobial Agents and Chemotherapy 1987, 31: 671–672.

    PubMed  Google Scholar 

  40. N'Deli L, Guelpa-Lauras CC, Perani EG, Grosset JH Effectiveness of pefloxacin in the treatment of lepromatous leprosy. International Journal of Leprosy 1990, 58: 23–28.

    Google Scholar 

  41. Grosset JH, Ji B, Guelpa-Lauras CC, Perani EG, N'Deli LN Clinical trial of pefloxacin and ofloxacin in the treatment of lepromatous leprosy. International Journal of Leprosy 1990, 58: 281–295.

    Google Scholar 

  42. Pearson JMH, Rees RJW, Waters MFR Sulphone resistance in leprosy: a review of one hundred proven clinical cases. Lancet 1975, 69: 72.

    Google Scholar 

  43. Shepard CC Combinations of drugs againstMycobacterium leprae studied in mice. International Journal of Leprosy 1972, 40: 33–39.

    Google Scholar 

  44. Shepard CC Combinations involving dapsone, rifampin, clofazimine, and ethionamide in the treatment ofM. leprae infections in mice. International Journal of Leprosy 1976, 44: 135–139.

    Google Scholar 

  45. Gelber RH, Henika PR, Gibson JB The bactericidal activity of various aminoglycoside antibiotics againstM. leprae in mice. Leprosy Review 1984, 55: 341–347.

    PubMed  Google Scholar 

  46. Gelber RH Further studies of the killing ofM. leprae by aminoglycosides: reduced dosage and frequency of administration. International Journal of Leprosy 1987, 55: 78–82.

    Google Scholar 

  47. Fieldsteel AH andLevy L Dapsone chemotherapy ofMycobacterium leprae infection of the neonatally thymectomized Lewis rat. American Journal of Tropical Medicine and Hygiene 1976, 25: 854–859.

    PubMed  Google Scholar 

  48. Fieldsteel AH, Levy L Combination dapsone-rifampicin therapy in neonatally thymectomized Lewis rats (NTLR) chronically infected withMycobacterium leprae. International Journal of Leprosy 1979, 47: 108–110.

    Google Scholar 

  49. Fieldsteel AH, Levy L Combined rifampin and dapsone chemotherapy ofMycobacterium leprae infection of the neonatally thymectomized Lewis rat. International Journal of Leprosy 1980, 48: 267–276.

    Google Scholar 

  50. Waters MFR, Rees RJW, McDougall AC, Weddell AGM Ten years of dapsone in lepromatous leprosy: clinical, bacteriological and histological assessment and the findings of viable leprosy bacilli. Leprosy Review 1974, 45: 288–298.

    PubMed  Google Scholar 

  51. Waters MFR, Rees RJW, Pearson JMH, Laing ABG, Helmy HS, Gelber RH Rifampicin for lepromatous leprosy: nine years' experience. British Medical Journal 1978, 1: 133–136.

    PubMed  Google Scholar 

  52. Subcommittee on Clinical Trials of the Chemotherapy of Leprosy (THELEP) Scientific Working Group of the UNDP/World Bank/WHO Special Programme for Research and Training in Tropical Diseases PersistingMycobacterium leprae among THELEP trial patients in Bamako and Chingleput. Leprosy Review 1987, 58: 325–337.

    Google Scholar 

  53. Gelber RH, Levy L Detection of persistingMycobacterium leprae by inoculation of the neonatally thymectomized rat. International Journal of Leprosy 1987, 55: 872–878.

    Google Scholar 

  54. Gelber RH, Humphres RC, Fieldsteel AH Superiority of the neonatally thymectomized Lewis rat (NTLR) to monitor a clinical trial in lepromatous leprosy of the two regimens of rifampin and dapsone. International Journal of Leprosy 1986, 54: 273–283.

    Google Scholar 

  55. Hobby GL, Meyer K, Chaffee E Observations on the mechanism of action of penicillin. Proceedings of the Society for Experimental Biology and Medicine 1942, 50: 281–285.

    Google Scholar 

  56. Hobby GL, Lennert TF The in vitro action of antituberculous agents against multiplying and non-multiplying microbial cells. American Review of Tuberculosis and Pulmonary Disease 1957, 76: 1031–1048.

    Google Scholar 

  57. Bigger JW Treatment of staphylococcal infections with penicillin by intermittent sterilisation. Lancet 1944, 247: 497–500.

    Article  Google Scholar 

  58. Brouet G, Roussel G General report trial 6.9.12. Overall methods and results. Revue Française des Maladies Respiratoires 1977, 5: 5–13.

    Google Scholar 

  59. East African/British Medical Research Council Study Results at 5 years of a controlled comparison of a 6-month and a standard 18-month regimen of chemotherapy for pulmonary tuberculosis. American Review of Respiratory Diseases 1977, 116: 3–8.

    Google Scholar 

  60. Kreis B, Pretet S, Birenbaurn J, Guibaut P, Hazeman JJ, Orin E, et al. Two three-month treatment regimens for pulmonary tuberculosis. Bulletin of the International Union against Tuberculosis 1976, 51: 71–75.

    PubMed  Google Scholar 

  61. Tuberculosis Research Centre Madras and National Tuberculoisis Institute, Bangalore A controlled clinical trial of 3- and 5-month regimens in the treatment of sputum-positive pulmonary tuberculosis in South India. American Review of Respiratory Diseases 1986, 134: 27–33.

    Google Scholar 

  62. Toyahara M Experimental short-course chemotherapy with conventional mice and nude mice. Bulletin of the International Union against Tuberculosis 1979, 54: 54.

    Google Scholar 

  63. Grosset J, Grumbach F, Rist R Le rôle de la rifampicine dans la phase ultime du traitement de la tuberculose murine expérimentale. Revue Française des Maladies Respiratoires 1978, 6: 515–520.

    Google Scholar 

  64. Grumbach F La durée optimale de l'antibiothérapie par l'association isoniazide + rifampicine dans la tuberculose expérimentale de la souris. Étude de la phase post-thérapeutique. Épreuve de la cortison. Revue Française des Maladies Respiratoires 1975, 3: 625–634.

    Google Scholar 

  65. Nath I, Curtis J, Sharma AK, Talwar GP Circulating T-cell numbers and their mitogenic potential in leprosy-correlation with mycobacterial load. Clinical and Experimental Immunology 1977, 29: 393–400.

    PubMed  Google Scholar 

  66. Esquenazi DA, Sampaio EP, Moreira AL, Gallo MEN, Almeida SMR, Sarmo EN Effect of treatment on immune responsiveness in lepromatous leprosy patients. Leprosy Review 1990, 61: 251–257.

    PubMed  Google Scholar 

  67. Cree IA, Smith WCS, Rees RJW, Swanson Beck J The influence of antimycobacterial chemotherapy on delayed hypersensitivity skin-test reactions in leprosy patients. Leprosy Review 1988, 59: 145–151.

    PubMed  Google Scholar 

  68. Grosset JH, Guelpa-Lauras, CC Activity of rifampin in infections of normal mice withMycobacterium leprae. International Journal of Leprosy 1987, 55: 847–851.

    Google Scholar 

  69. Pattyn SR Search for effective short-course regimens for the treatment of leprosy. International Journal of Leprosy 1993, 61: 76–81.

    Google Scholar 

  70. Noordeen SK A look at world leprosy. Leprosy Review 1991, 62: 72–86.

    PubMed  Google Scholar 

  71. Grosset JH, Guelpa-Lauras CC, Bobin P, Brucker G, Cartel JL, Constant-Desportes M, Flageul B, Frédéric M, Guillaume JC, Millan J Study of 39 documented relapses of multibacillary leprosy after treatment with rifampin. International Journal of Leprosy 1989, 57: 607–614.

    Google Scholar 

  72. Colston MJ Application of the thymectomized-irradiated mouse to the detection of persistingMycobacterium leprae. International Journal of Leprosy 1987, 55: 859–863.

    Google Scholar 

  73. Convit J, Sampson C, Zuniga M, Smith PG, Plata J, Silva J, Molina J, Pinardi ME, Bloom BR, Salgado A Immunoprophylactic trial in combinedMycobacterium leprae/BCG vaccine against leprosy: preliminary results. Lancet 1992, 339: 446–450.

    Article  PubMed  Google Scholar 

  74. Kaplan G, Gandhi RR, Weinstein DE, Levis WR, Patarroyo ME, Brennan PJ, Cohn ZA Mycobacterium leprae antigen-induced suppression of T cell proliferation in vitro. Journal of Immunology 1987, 138: 3028–3034.

    Google Scholar 

  75. Mehra V, Brennan PJ, Rada E, Convit J, Bloom BR Lymphocyte suppression in leprae induced by uniqueMycobacterium leprae glycolipid. Nature 1984, 308: 194–196.

    Article  PubMed  Google Scholar 

  76. Sibley LD, Hunter SW, Brennan PJ, Krahenbuhl JL Mycobacterial lipoarabinomannan inhibits gamma interferon-mediated activation of macrophages. Infection and Immunity 1983, 56: 1232–1236.

    Google Scholar 

  77. Gelber RH, Murray L, Siu P, Tsang M Vaccination of mice with a soluble protein fraction ofMycobacterium leprae provides consistent and long-term protection againstM. leprae infection. Infection and Immunity 1992, 60: 1840–1844.

    PubMed  Google Scholar 

  78. Gelber RH, Brennan PJ, Hunter SW, Munn MW, Monson JM, Murray LP, Siu P, Tsang M, Engleman EG, Mohagheghpour N Effective vaccination of mice against leprosy bacilli with subunits ofMycobacterium leprae. Infection and Immunity 1990, 58: 711–718.

    PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Regional Hansen's Disease Program, 2211 Post St., Suite 301, 94115, San Francisco, California, USA

    R. H. Gelber

Authors
  1. R. H. Gelber
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Gelber, R.H. Chemotherapy of lepromatous leprosy: Recent developments and prospects for the future. Eur. J. Clin. Microbiol. Infect. Dis. 13, 942–952 (1994). https://doi.org/10.1007/BF02111496

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF02111496

Keywords

Search

Navigation